Bourgeon Capital Management LLC Biogen Inc. Transaction History

Bourgeon Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$193.77 - $244.14 $193,770 - $244,140	1,000 New	1,000 $211,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $28,229 - $35,809	-105 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$220.06 - $304.07 $5,501 - $7,601	-25 Reduced 19.23%	105 $31,000
Q3 2019 Nov 04, 2019	BUY	$217.44 - $243.88 $28,267 - $31,704	130 New	130 $30,000
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $3.05 Million - $4.77 Million	-14,066 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$278.5 - $352.75 $6,962 - $8,818	-25 Reduced 0.18%	14,066 $4.23 Million
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $1.5 Million - $1.97 Million	-5,125 Reduced 26.67%	14,091 $4.98 Million
Q2 2018 Jul 19, 2018	SELL	$257.52 - $306.91 $3,862 - $4,603	-15 Reduced 0.08%	19,216 $5.58 Million
Q1 2018 Apr 27, 2018	BUY	$260.13 - $367.91 $1.46 Million - $2.07 Million	5,615 Added 41.24%	19,231 $5.27 Million
Q4 2017 Feb 05, 2018	SELL	$307.64 - $344.58 $33,840 - $37,903	-110 Reduced 0.8%	13,616 $4.34 Million
Q3 2017 Oct 27, 2017	BUY	$281.15 - $329.69 $3.86 Million - $4.53 Million	13,726	13,726 $4.3 Million

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bourgeon Capital Management LLC with notifications on news.